3 Nuclear Stocks Worth Buying as the World Scrambles for Reliable Power

The article highlights three nuclear stocks positioned to benefit from rising reactor demand, AI data center power needs, and advanced reactor development. Cameco is described as the largest publicly traded uranium miner with exposure to an $80 billion Westinghouse reactor partnership, while Nano Nuclear and Oklo are advancing portable microreactors and AI-focused small modular reactors. The tone is constructive but speculative, with company-specific upside tied to long-cycle nuclear buildout rather than near-term financial results.

Analysis

The cleanest second-order winner is not the reactor developers, but the constrained upstream uranium supply chain. If the AI buildout keeps pulling forward power demand, the bottleneck shifts from reactor count to fuel availability and permitting, which structurally favors the scarce, established miner over the more promotional names; in that regime, pricing power accrues to the few with scale, long-life assets, and balance-sheet flexibility. The market is still underwriting a simple “nuclear = all winners” narrative, but in practice the spread between durable cash flow and speculative optionality should widen as capital becomes more selective.

The more interesting asymmetry is that small-modular and microreactor stories can be rewarded long before first revenue, but only if they keep de-risking licensing and fuel procurement. That creates a binary catalyst path over the next 12-24 months: successful regulatory milestones can re-rate the names sharply, while even modest slippage can compress multiples fast because the equity value is heavily based on timing, not current earnings. Investors should expect high sensitivity to headlines around NRC progress, DOE support, and any credible HALEU supply announcements.

A likely underappreciated pressure point is the infrastructure layer: transport, enrichment, and fuel fabrication become rate-limiting steps before reactor deployment does. That creates a potential squeeze on vendors and service providers with regulatory moats, while also increasing the odds that larger incumbents or strategically backed platforms win share from pure-play startups. The consensus seems to be pricing in a smooth nuclear renaissance; the more realistic path is a staggered rollout with occasional supply-chain chokepoints and financing resets, which argues for relative-value positioning rather than outright beta chasing.

Key Decisions for Investors

• Long CCJ on 6-12 month horizon: best risk-adjusted exposure to rising uranium demand and fuel scarcity; use any pullback tied to broader risk-off as entry, with upside driven by contract repricing rather than reactor headlines.
• Pair trade long CCJ / short NNE for the next 3-6 months: express the view that scarce current cash flow and resource optionality will outperform pre-commercial story stocks as financing markets tighten.
• Trade OKLO with defined risk via call spreads into the next 6-12 months: only if willing to own licensing volatility; catalyst window is NRC milestones and pilot-reactor validation, but downside is sharp on timing slippage.
• Avoid chasing SMR until execution evidence improves: the market is likely to reward whichever developer can show concrete regulatory and customer conversion progress first; until then, the stock has more valuation fragility than the better-capitalized peers.
• For higher-conviction event exposure, consider a basket long CCJ and BEP against a smaller short in speculative nuclear equities: captures the infrastructure/fuel buildout while hedging the part of the trade most vulnerable to hype compression.